Table 2.

Outcome.

	LSA-sign− (n = 34)	LSA-sign+ (n = 64)	p
Final infarct volume, mL	18 (6–81)	20 (8–40)	0.796
HI	50.0% (17)	39.1% (25)	1.000
PH	2.9% (1)	1.6% (1)	0.391
In-hospital mortality	2.9% (1)	1.6% (1)	1.000
NIHSS-DIS	8 (5–12)	4 (1–7)	0.003
Substantial neurologic improvement	41.2% (14)	68.8% (44)	0.010
Good neurologic outcome	17.6% (6)	85.7% (36)	<0.001
Barthel index-DIS	15 (5–55)	50 (25–75)	0.010
mRS-DIS (n = 91)	4 (3–5)	2 (1–4)	<0.001
Good functional short-term outcome (mRS-DIS≤2, n = 91)	17.6% (6/34)	56.1% (32/57)	<0.001
d90 mRS (n = 75)	2 (1–3)	1 (1–2)	0.016
Good function mid-term outcome (d90 mRS ≤ 2, n = 75)	54.2% (13/24)	82.4% (42/51)	0.014

HI: hemorrhagic infarction; PH: parenchymal hematoma; DIS: discharge; d90: day 90 after admission.